⚖️DEA Revokes Prescript Pharmaceuticals' Registration for Violations
The Drug Enforcement Administration issued an Order of Revocation against Prescript Pharmaceuticals after it violated federal regulations pertaining to the procurement of controlled substances. The order highlights the importance of compliance with the Controlled Substances Act, especially concerning the requirement for obtaining procurement quotas for manufacturing activities, and could set a precedent affecting other registrants.
Learn More🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial
The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.
Learn More🌱DEA Notice of Application for Bulk Manufacturing of Marihuana
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More🌿DEA Notice for Bulk Manufacturer of Marihuana
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More💊Notice of Application for Bulk Manufacturing by Promega Corporation
Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊SpecGx LLC Controlled Substances Import Application Overview
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️Restek Corporation's Import Application for Controlled Substances Notice
Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More💊Patheon API Services’ Application for Controlled Substances Import
Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More🍃DEA Notice on Bulk Manufacturing of Controlled Substances
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More🌿Royal Emerald Pharmaceuticals' Application for Controlled Substances Registration
Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More